Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.900
+0.030 (1.05%)
At close: Mar 5, 2026, 4:00 PM EST
2.960
+0.060 (2.07%)
After-hours: Mar 5, 2026, 7:35 PM EST
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $373.06 million as of March 5, 2026. Its market cap has decreased by -18.71% in one year.
Market Cap
373.06M
Enterprise Value
359.27M
1-Year Change
-18.71%
Ranking
Category
Stock Price
$2.90
Market Cap Chart
Since January 8, 2019, Organogenesis Holdings's market cap has decreased from $1.24B to $373.06M, a decrease of -69.83%. That is a compound annual growth rate of -15.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 369.20M | -43.84% |
| Dec 31, 2025 | 657.40M | 63.40% |
| Dec 31, 2024 | 402.32M | -25.09% |
| Dec 29, 2023 | 537.07M | 52.51% |
| Dec 30, 2022 | 352.16M | -70.37% |
| Dec 31, 2021 | 1.19B | 23.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ironwood Pharmaceuticals | 609.84M |
| Aquestive Therapeutics | 533.15M |
| Kamada | 525.32M |
| Eton Pharmaceuticals | 470.11M |
| SIGA Technologies | 456.16M |
| Emergent BioSolutions | 454.03M |
| Canopy Growth | 409.20M |
| Evolus | 363.69M |